A Structured Classification of Pyrotinib-Containing Neoadjuvant Regimens for HER2-Positive Breast Cancer: Efficacy, Safety, and Regimen Selection
Breast Cancer: Targets and Therapy · 2026-05 · Volume 18 · 1-10
DOI: 10.2147/bctt.s600575 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-05. Verfasst von Jiani Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Baoding No. 1 Central Hospital, Baoding, Hebei, 071000, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Baoding No. 1 Central Hospital, Baoding, Hebei, 071000, People's Republic of China.
- Department of Gastrointestinal Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, People's Republic of China.
- Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, People's Republic of China.
ORCID-Profile: Jiani Liu, Yongtao Du
Zitieren
APA
Liu, J., Peng, X., Yang, Y., Huang, X., Du, Y., & Liu, K. (2026). A Structured Classification of Pyrotinib-Containing Neoadjuvant Regimens for HER2-Positive Breast Cancer: Efficacy, Safety, and Regimen Selection. Breast Cancer: Targets and Therapy, Volume 18, 1-10. https://doi.org/10.2147/bctt.s600575
Vancouver
Liu J, Peng X, Yang Y, Huang X, Du Y, Liu K. A Structured Classification of Pyrotinib-Containing Neoadjuvant Regimens for HER2-Positive Breast Cancer: Efficacy, Safety, and Regimen Selection. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-10. doi:10.2147/bctt.s600575
BibTeX
@article{Liu2026,
author = {Liu, Jiani and Peng, Xinyu and Yang, Yang and Huang, Xuhui and Du, Yongtao and Liu, Keming},
title = {A Structured Classification of Pyrotinib-Containing Neoadjuvant Regimens for HER2-Positive Breast Cancer: Efficacy, Safety, and Regimen Selection},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--10},
doi = {10.2147/bctt.s600575}
}
EUVIMED